Trial Outcomes & Findings for Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes (NCT NCT03955952)

NCT ID: NCT03955952

Last Updated: 2026-08-03

Results Overview

First occurrence of all-cause mortality, coronary artery disease event, stroke, heart failure, nephropathy, or atrial fibrillation

Recruitment status

COMPLETED

Target enrollment

91700 participants

Primary outcome timeframe

From index date through a maximum of 8 years

Results posted on

2026-08-03

Participant Flow

Retrospective chart review of 287, 428 patients with Diabetes in the Cleveland Clinic health system between 1998-2017

Participant milestones

Participant milestones
Measure
Bariatric Surgery
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Overall Study
STARTED
2757
88943
Overall Study
COMPLETED
2287
11435
Overall Study
NOT COMPLETED
470
77508

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Bariatric Surgery
n=2287 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=11435 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Total
n=13722 Participants
Total of all reporting groups
Age, Continuous
52.5 years
n=20 Participants
54.8 years
n=20 Participants
54.4 years
n=40 Participants
Sex: Female, Male
Female
1499 Participants
n=20 Participants
7339 Participants
n=20 Participants
8838 Participants
n=40 Participants
Sex: Female, Male
Male
788 Participants
n=20 Participants
4096 Participants
n=20 Participants
4884 Participants
n=40 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Asian
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Black or African American
441 Participants
n=20 Participants
2804 Participants
n=20 Participants
3245 Participants
n=40 Participants
Race (NIH/OMB)
White
1734 Participants
n=20 Participants
7994 Participants
n=20 Participants
9728 Participants
n=40 Participants
Race (NIH/OMB)
More than one race
54 Participants
n=20 Participants
234 Participants
n=20 Participants
288 Participants
n=40 Participants
Race (NIH/OMB)
Unknown or Not Reported
58 Participants
n=20 Participants
403 Participants
n=20 Participants
461 Participants
n=40 Participants
BMI
45.1 kg/m^2
n=20 Participants
42.6 kg/m^2
n=20 Participants
42.9 kg/m^2
n=40 Participants

PRIMARY outcome

Timeframe: From index date through a maximum of 8 years

Population: All enrolled participants

First occurrence of all-cause mortality, coronary artery disease event, stroke, heart failure, nephropathy, or atrial fibrillation

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=2287 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=11435 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
All-Cause Mortality and/or Cardiovascular Outcomes
30.8 percentage of participants
Interval 27.6 to 34.0
47.7 percentage of participants
Interval 46.1 to 49.2

SECONDARY outcome

Timeframe: From index date through a maximum of 8 years

Population: All enrolled participants

First occurrence of all-cause mortality, myocardial infarction or ischemic stroke

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=2287 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=11435 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Major Adverse Cardiovascular Event (MACE-3)
17 percentage of participants
Interval 14.3 to 19.7
27.6 percentage of participants
Interval 26.2 to 29.0

SECONDARY outcome

Timeframe: From index date through a maximum of 8 years

Population: All enrolled participants

Occurrence of death from any cause

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=2287 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=11435 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
All-Cause Mortality
4.9 percentage of participants
Interval 7.8 to 12.2
9.72 percentage of participants
Interval 16.6 to 19.0

SECONDARY outcome

Timeframe: From index date through a maximum of 8 years

Population: Enrolled participants without a history of the outcome (coronary disease events)

First occurrence of myocardial infarction, unstable angina, percutaneous coronary intervention, or coronary artery bypass grafting

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=2050 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=10331 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Coronary Disease Events
7.9 percentage of participants
Interval 5.9 to 9.8
11.6 percentage of participants
Interval 10.5 to 12.6

SECONDARY outcome

Timeframe: From index date through a maximum of 8 years

Population: Enrolled participants without a history of the outcome (cerebrovascular events)

First occurrence of ischemic or hemorrhagic stroke, carotid stenting or endarterectomy

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=2245 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=11077 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Cerebrovascular Events
4.1 percentage of participants
Interval 2.7 to 5.5
5.6 percentage of participants
Interval 4.9 to 6.3

SECONDARY outcome

Timeframe: From index date through a maximum of 8 years

Population: Enrolled participants without a history of the outcome (heart failure)

First occurrence of heart failure

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=2049 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=10093 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Heart Failure
6.8 percentage of participants
Interval 4.9 to 8.6
18.9 percentage of participants
Interval 17.6 to 20.2

SECONDARY outcome

Timeframe: From index date through a maximum of 8 years

Population: Enrolled participants without a history of the outcome (nephropathy)

First occurrence of nephropathy defined as \>=2 measures of estimated Glomerular Filtration Rate (eGFR) \<60 ml/min/1.73m\^2 separated by at least 90 days without intervening values \>=60

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=1937 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=9190 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Development of Nephropathy
6.1 percentage of participants
Interval 4.4 to 7.8
16.3 percentage of participants
Interval 15.0 to 17.6

SECONDARY outcome

Timeframe: From index date through a maximum of 8 years

Population: Enrolled participants without a history of the outcome (atrial fibrillation)

First occurrence of atrial fibrillation defined by the following codes: International Classification of Diseases ICD-9: 427.31 ICD-10: i48.0, i48.1, i48.2, i48.91 Current Procedural Terminology (CPT): 93650, 93653, 93656, 93657

Outcome measures

Outcome measures
Measure
Bariatric Surgery
n=2135 Participants
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
n=10734 Participants
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Atrial Fibrillation
7.9 percentage of participants
Interval 6.1 to 9.7
13.6 percentage of participants
Interval 12.5 to 14.7

Adverse Events

Bariatric Surgery

Serious events: 169 serious events
Other events: 0 other events
Deaths: 112 deaths

Non-Surgical Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1111 deaths

Serious adverse events

Serious adverse events
Measure
Bariatric Surgery
n=2287 participants at risk
Patients with type 2 diabetes with BMI \>=30 that underwent bariatric surgery Bariatric Surgery: Patients chosen using the following codes: Current Procedural Terminology (CPT): 43633, 43634, 43770, 43775, 43644, 43645, 43659, 43842, 43843, 43844, 43845, 43846, 43847 International Classification of Diseases (ICD): 44.31, 43.82,44.95, 43.89, 44.38, 44.39, 44.68 Healthcare Common Procedure Coding System (HCPCS): S2082, S2085
Non-Surgical Control
Matched non-surgical controls with type 2 diabetes and BMI \>=30
Renal and urinary disorders
Renal Failure requiring dialysis
0.17%
4/2287 • Number of events 4 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
0/0 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
Vascular disorders
Bleeding requiring transfusion
3.0%
68/2287 • Number of events 68 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
0/0 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
Respiratory, thoracic and mediastinal disorders
Pulmonary Adverse Events
2.5%
58/2287 • Number of events 58 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
0/0 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
Vascular disorders
Venous Thrombosis
0.96%
22/2287 • Number of events 22 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
0/0 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
Cardiac disorders
Cardiac events
0.74%
17/2287 • Number of events 17 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.
0/0 • 8 years
Only mortality was reported for both groups. 90-day postoperative adverse events of bariatric surgery were reported. Adverse events were not collected real time and were based on retrospective chart review. Due to this method, no distinction was made between Serious and Non-Serious as the study team did not feel they had enough information to adequately assess the situation. Adverse events in the nonsurgical group (beside the mortality) are not reported.

Other adverse events

Adverse event data not reported

Additional Information

Dr. Ali Aminian

Cleveland Clinic

Phone: 216-444-6704

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place